SkinCure Oncology reports 150,000 patients treated with its GentleCure IGSRT technology, underscoring the firm's growing commercial presence in the nonmelanoma skin cancer sector.
SkinCure Oncology announces a 150,000th patient milestone for its GentleCure treatment, indicating commercial traction but providing no financial details.
SkinCure Oncology has reached a significant operational milestone, treating its 150,000th patient using the GentleCure Image-Guided Superficial Radiation Therapy (IGSRT) system. The company continues to expand its footprint in the nonmelanoma skin cancer treatment market through its specialized cancer center model.
The milestone demonstrates the widespread adoption and commercial traction of the company's Image-Guided Superficial Radiation Therapy (IGSRT) for nonmelanoma skin cancer.